DIAGNOS Announces Successful Pilot at Chaparral Medical Group in California and a 3 Year Contract with the Opening of a Second Eye Screening Clinic

BROSSARD, QUEBEC--(Marketwired - July 5, 2017) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces today the signing of a three year agreement with Chaparral Medical Group ("Chaparral"). We are also happy to announce the opening of a second eye screening clinic in California.